AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Neurogene Inc. Director's Dealing 2017

Mar 27, 2017

33497_dirs_2017-03-27_09b737b8-5575-47f2-a49f-0ad7a25716e3.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AQUINOX PHARMACEUTICALS, INC (AQXP)
CIK: 0001404644
Period of Report: 2017-03-23

Reporting Person: Neu Kelvin (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	36	Direct